One out of four new molecular entities approved by regulatory authorities provides substantial benefit over existing studies.

Every Sunday: the week’s new conflicts and verdict changes — and nothing else.

Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.